2nd Health meets Future Summit

The digitalization now also reaches the health sector. This year’s Health meets Future Summit takes into account the increasing transformation of the health sector and is dedicated to digital innovations in medicine, the pharmaceutical industry, life sciences and biotech.

International masterminds and decision-makers will discuss key questions regarding the digital transformation on the highest level:

– How can digitalization foster better health and care, economic growth and sustainable health systems?
– What can we expect from the future of precision medicine and how can patient care benefit from this?
– How can we develop digital business models and which data privacy issues do we have to keep in mind?
– What are the most innovative and disruptive topics in the digital health sector?

The conference language is English.

The hashtag for the conference is #HealthSummit.

Speakers (extract)

Dr. Boris Adryan

Dr. Boris Adryan

Dr. Boris Adryan

Chief Digital Officer / Expert for IoT & Data Analytics, Merck KGaA

Dr. Boris Adryan is a molecular biologist by training, with about 50 peer-reviewed publications in the life sciences. From 2008 to 2016 he was a Royal Society research group leader for computational genomics at the University of Cambridge, where he also taught data science and machine learning in an interdisciplinary degree programme. From 2014 his interests shifted to technology and connected products. In the meantime, Dr. Adryan has become an internationally renowned expert for IoT and M2M, and he is the lead author of “The Technical Foundations of IoT” (Artech House, Boston/London). After a short stint as Head of IoT & Data Analytics at Zühlke Engineering GmbH, he is now acting as expert and consultant within the Chief Digital Office at chemical and pharmaceutical company Merck KGaA.

Dušan Beblavý

Dušan Beblavý

Chief Technical Officer Medical Technologies for Europe, GlobalLogic

Prof. Dr. Hans-Hermann Dirksen

Prof. Dr. Hans-Hermann Dirksen

Prof. Dr. Hans-Hermann Dirksen

Professor of medical and health law, Hochschule Fresenius Frankfurt – University of Applied Sciences

Dr. Armin Furtwaengler

Dr. Armin Furtwaengler

Dr. Armin Furtwaengler

Global Senior Medical Director - Health Care Innovation, Boehringer Ingelheim

Dr. Jutta Heix

Dr. Jutta Heix

Dr. Jutta Heix

International Advisor, Oslo Cancer Cluster

Dr. Jutta Heix is a life science professional with more than 20 years of industry experience. She holds a PhD in molecular biology from the University of Heidelberg /German Cancer Research Center and has worked in different Business Development roles in international pharma and biotech companies prior to joining Oslo Cancer Cluster.

Prof. Dr. Berthold Huppertz

Prof. Dr. Berthold Huppertz

Prof. Dr. Berthold Huppertz

Chair, Department of Cell Biology, Histology & Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria

Prof. Dr. Hans Lehrach

Prof. Dr. Hans Lehrach

Prof. Dr. Hans Lehrach

Director, Max Planck Institute for Molecular Genetics; Founder, Alacris Theranostics GmbH

The main focus of Prof. Lehrach’s research at the MPI of Molecular Genetics, the Dahlem Center for Genome Research and Medical Systems Biology and Alacris Theranostics GmbH is the development of methods for predicting the behaviour of the complex biological systems, through a combination of genetics, genomics, bioinformatics and systems biology techniques. This makes it possible, on the basis of a detailed molecular examination of tumor patients, to develop computer models of the individual patient, ie ‘virtual patient models’, which can systematically test all theoretically possible therapies. Thus, the optimal therapy for the individual patient, with a possible reduction of side effects, can be identified and made available to the patient.These techniques can also be used for drug development, testing the many steps involved first on a computer model. Thus, ‘virtual clinical trials’ can reduce the risks of developing new drugs at an early stage, reducing costs and accelerate timelines.

Dr. Mark Lightowler

Dr. Mark Lightowler

Dr. Mark Lightowler

Founder and CEO, Phorix Limited

Mark originally trained as a medicinal chemist in England and has a Ph.D. and post-Doctoral experience from Bath University. During the last twenty years he has worked across many roles from drug discovery, clinical development, sales and marketing. As global head of digital solutions for respiratory at Novartis he was focused on digital healthcare innovation, where technology meets health outcomes.
Two years ago he started Phorix Limited, a Basel and London based company focusing on catalyzing innovation and harnessing the power of Patient-Led design to improve healthcare interventions.
Separately he writes on the science and art of storytelling and how to make science memorable.

Herna Muñoz-Galeano

Herna Muñoz-Galeano

Herna Muñoz-Galeano

Managing Director, HMG Systems Engineering GmbH

Herna Muñoz-Galeano has over 25 years of experience in specification, development, integration and management of complex engineering systems. Since 1998, Herna has been an independent entrepreneur with a special interest in transforming science into innovative products and systems. She also has knowledge of standardization at ITU, ETSI and IEEE. She has perfected the methods which optimize the development process, including integration and testing processes, for breakthrough complex technical systems. By applying the “functional anatomy” method, all projects have been completed within the given time frame and budget Herna’s way of working is analytic and systematic and has made her who she is today. Respect, openness and trust are very important to her. Her employees and customers value her fast and logical judgment as well as her reliability and social competence. She is clientservice oriented and is always open for new challenges. Due to her international background, Herna Muñoz-Galeano speaks English and German fluently and Spanish is her native language. She has implemented projects in Germany, Sweden, Spain, the Netherlands, the United Kingdom and Brazil. Herna Muñoz-Galeano holds a master’s degree in Electronics Engineering from the Universidad Distrital Francisco José de Caldas in Bogotá, Colombia, and a master’s degree in Computer Science from the Friedrich-Alexander-University in Erlangen-Nuernberg, Germany. On 29th April 2016, Herna Muñoz-Galeano was awarded the Career Award “Engineer PowerWoman 2016” by the Deutsche Messe AG at the Hannover Messe. Since 1998, Herna has been an independent entrepreneur and managing director of HMG Systems Engineering GmbH, which emerged in 2014 from the merger of two other companies established by Herna. HMG Systems Engineering GmbH was awarded in 2016 as one of the Top 100 (top100.de) most innovative SMEs in Germany.

Dr. Yoshiyuki Sankai

Dr. Yoshiyuki Sankai

Dr. Yoshiyuki Sankai

CEO and President, CYBERDYNE, INC., Professor Dr., University of Tsukuba, Program Manager, ImPACT, promoted by Cabinet Office, Government of Japan

Yoshiyuki Sankai is a professor and Executive Research Director at the Center for Cybernics Research, University of Tsukuba; the President and CEO of CYBERDYNE, INC.; and a Program Manager of the Impulsing Paradigm Change through Disruptive Technologies (“ImPACT”) program, which was initiated by the Council for Science, Technology and Innovation (“CSTI”) of the Cabinet Office in Japan. He is a fellow of the Robotics Society of Japan (“RSJ”) and the Society of Instrument and Control Engineers (“SICE”) . He also served as Chairman and an Executive Board Member of Advanced Robotics. He is a member of Global Future Council on Human Enhancement of the World Economic Forum.
He has received numerous awards, including: The 2005 World Technology Award (World Technology Network), The 2012 Capek Award (INNOROBO), The 2014 Technology Pioneer (World Economic Forum), Gold Prize of 2014 Edison Awards, DealWatch Awards 2013 IPO of the Year (Thomson Reuters), DealWatch Awards 2014 Innovative Equity Deal of the Year (Thomson Reuters), The 2016 DIA Japan Outstanding Contribution to Health Award, the 7th Robot Award (Ministry of Health, Labour and Welfare award), and the Prime Minister’s Award (the third Nippon Venture Awards) in 2017.

Arantxa Unda

Arantxa Unda

Arantxa Unda

CEO, Sigesa

Jens von der Brelie

Jens von der Brelie

Jens von der Brelie

Partner, Zühlke

Jens von der Brelie joined Zühlke in 2011 where he is working with customers and partners to design and deliver IoT solutions for Medtech and Pharma. He has a long track record, in the development and the application of automation, controls and IoT in various industries. He holds a Dipl.-Ing. degree in Electrical Engineering with a major in data technology from the Braunschweig University of Technology.

Impressions 2017

Premium Partner

Partner

Supporter

Networking Partner

Media Partner

Official Printing Partner

Sponsoring

Registration Services

Location

Westhafen Pier 1
Rotfeder-Ring 1
60327 Frankfurt am Main

You're using a deprecated browser. Please update your browser, in order to view this website in its entirety. x